Navigation Links
Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants

LAKE FOREST, Ill., Jan. 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made initial donations of approximately $1.75 million in medical products and cash grants to support humanitarian relief efforts in Haiti. More than 750,000 units of Hospira products, valued at more than $1.5 million, are either in Haiti or en route to the country and include antibiotics, intravenous (I.V.) solutions, analgesics and anesthetics, all of which are in high demand and are integral to serving the needs of disaster victims.

"We are working closely with humanitarian aid agencies to help the people of Haiti obtain access to critical products needed in the provision of medical care," said Christopher B. Begley, chairman and chief executive officer. "The Hospira family expresses deep sympathy to all of the victims of this tragedy, and we will continue to work in the coming weeks and months to provide health and wellness to this devastated region."

In addition to donating products, Hospira has made a total of $200,000 in initial cash grants to the Red Cross and to the company's partners, which include AmeriCares, Direct Relief International, Catholic Medical Mission Board (CMMB) and Project Hope. Hospira also will match employee contributions dollar for dollar up to $50,000 through the Hospira Foundation.

Hospira will continue to monitor disaster relief efforts in Haiti, and will evaluate opportunities to provide additional assistance as further needs and information become available.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at

SOURCE Hospira, Inc.



SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
2. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
3. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
4. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
5. Hospira Reports Third-Quarter 2009 Results
6. Hospira Names Daphne E. Jones Chief Information Officer
7. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
8. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
9. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. PROXY Governance Recommends Against Taros Board and Supports Sun
Post Your Comments:
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    --> Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ...
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... UTRECHT , Niederlande, November 27, 2015 /PRNewswire/ ... mit fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... berichtet. --> Clinical Cancer Research ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... 2015 American Dental Association meeting in Washington D.C. revolved around the fact that proper ... overall health. The talk stressed the link between periodontal disease (more commonly referred to ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions ... SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of ... SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to announce ... (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored to ... of twelve colleges and universities in the state of California make the cut. CBD ...
Breaking Medicine News(10 mins):